The pharmaceutical industry has evolved into a global behemoth worth over a trillion dollars according to the latest 2025 forecast by Statista, making it one of the most vital businesses both when it comes to driving the global economy and protecting people’s health. The pharma industry's exponential growth has brought both opportunities and challenges as pharmaceutical companies are now under more pressure than ever to not only conform with industry regulations but also act responsibly and prioritize ethical business practices and environmental sustainability.
This now means, in the current day and age, our perception of compliance should not be limited to product quality and safety alone but should also incorporate other aspects of compliance in today’s regulatory landscape, such as sustainability, as reducing CO₂ emissions and minimizing raw material consumption have become central to corporate responsibility worldwide.